MRI Analysis in the Growth of Cerebral Aneurysms
ConditionUnruptured Intracranial Aneurysm
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCHU de Reims
About this trial
An intracranial aneurysm is defined as a localized dilatation of the cerebral arteries, which can potentially lead to rupture and subsequent hemorrhagic stroke. The mechanisms by which aneurysms develop and grow remain unknown. The objective of this project is to utilize MRI, a routine non-invasive examination for detecting and following up aneurysms, to identify visually and quantitatively an aneurysm growth and relevant biomarkers that can predict the risk of aneurysm development.
Eligibility criteria
Qualifiers
Patients with one or more unruptured intracranial aneurysms followed up at the participating center. Patients may have other ruptured and/or treated aneurysms
Patient older than 18 years
Patient consenting to participate to the study
Patient enrolled in the national healthcare insurance program
Disqualifiers
Patients who have already received surgical or endovascular treatment for all their aneurysm(s), or who are due to receive such treatment in less than 2 months.
Patients with only ruptured aneurysm(s)
Patients with arteriovenous malformations (treated or untreated)
Patients with a contraindication to MRI
Trial design
Treatments tested in this trial
- Additional 4D Flow MRI or additional 4D Flow sequence
Treatment groups
281 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov